The RAPS store will be under maintenance Saturday, 17 April between 5 AM and 12 PM EST. Store functionality may be unavailable at times during this window.
We apologize for any inconvenience caused during this time.

Regulatory Focus™ > News Articles > Brazil: New Manual For Labeling National Health Service Drugs

Brazil: New Manual For Labeling National Health Service Drugs

Posted 02 April 2012 | By Ansis Helmanis

A new manual for medicines intended for use by Brazil's National Health Service (NHS) has been prepared by the country's national regulatory agency, ANVISA. The Manual requires the labeling of such drugs to carry the non-proprietary name of the drug and to have the NHS seal on all drug packaging, blister packs, vials, and bottles. The labeling requirements are intended to encourage NHS medical professionals to prescribe using the generic name of the active ingredient of the product, rather than the brand name.


Read more:

Anvisa lança manual para rotulagem dos medicamentos do Ministério da Saúde

 

© 2021 Regulatory Affairs Professionals Society.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe